Korman Neil J, Zhao Yang, Lu Jackie, Tran Mary Helen
University Hospitals Case Medical Center.
Dermatol Online J. 2015 Jul 15;21(7):13030/qt69h903m6.
Patients with psoriasis are often dissatisfied with available treatments, but contributing factors are not well defined.
Examine relationships between psoriasis severity, patient characteristics, and treatment satisfaction.
Patients with psoriasis were classified into mild and moderate-to-severe groups based on self-reported data. Demographics, comorbidities, symptoms, and multiple treatment satisfaction outcomes were compared between groups. Predictors of patient satisfaction with treatment were examined using linear regression models.
The analyses included 773 patients (407 mild; 366 moderate-to-severe). The percentage of patients reporting satisfaction with treatment was low overall, ranging from 8.6% to 61.7% for the mild and 13.9% to 49.5% for the moderate-to-severe group. Satisfaction among biologics users was also low (≤53%; 50% of satisfaction rates <40%). Regression results consistently showed greater dissatisfaction with current treatment among moderately to severely affected patients.
Many psoriasis patients were dissatisfied with their treatment; moderate-to-severe patients expressed significantly less satisfaction than mild patients.
银屑病患者往往对现有治疗方法不满意,但相关影响因素尚不明确。
研究银屑病严重程度、患者特征与治疗满意度之间的关系。
根据患者自我报告的数据,将银屑病患者分为轻度和中度至重度两组。比较两组患者的人口统计学特征、合并症、症状以及多种治疗满意度结果。使用线性回归模型分析患者对治疗满意度的预测因素。
分析纳入773例患者(407例轻度;366例中度至重度)。总体而言,报告对治疗满意的患者比例较低,轻度组为8.6%至61.7%,中度至重度组为13.9%至49.5%。生物制剂使用者的满意度也较低(≤53%;50%的满意率<40%)。回归结果一致显示,中重度患者对当前治疗的不满程度更高。
许多银屑病患者对其治疗不满意;中度至重度患者的满意度明显低于轻度患者。